Platelet Inhibition by Ibuprofen

Mechanism of Platelet Inhibition

• The European Society of Cardiology notes that ibuprofen inhibits thromboxane A2 (TXA2)-dependent platelet function through competitive, reversible inhibition of the COX-1 enzyme, with a strength of evidence based on multiple studies 1, 2, 3
• At conventional anti-inflammatory dosages, ibuprofen generally inhibits platelet COX-1 activity by only 70-90%, which may be insufficient to adequately block platelet aggregation in vivo due to the substantial biosynthetic capacity of human platelets to produce TXA2, as reported by the European Heart Journal 1, 2

Clinical Implications for Drug Interactions

• The American Heart Association recommends that patients taking aspirin for cardiovascular protection should be advised to take aspirin at least 2 hours prior to ibuprofen to avoid negating aspirin's cardioprotective effects, based on evidence from studies on COX-1 inhibitors like ibuprofen 1, 2
• The concomitant administration of ibuprofen antagonizes the irreversible platelet inhibition induced by low-dose aspirin, which can have serious cardiovascular consequences, as noted by the European Heart Journal 1, 2, 3

Comparison with Other NSAIDs

• Unlike ibuprofen, selective COX-2 inhibitors do not antagonize aspirin's irreversible platelet inhibition, according to the European Heart Journal 1, 2
• Acetaminophen and diclofenac also do not antagonize aspirin's platelet effects, as reported by the European Heart Journal 1, 2

Common Pitfalls to Avoid

• The American College of Cardiology advises against assuming ibuprofen provides adequate antiplatelet protection comparable to aspirin—its effect is too weak and too transient for cardiovascular prophylaxis, based on evidence from studies on platelet inhibition 1, 2